Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

RDW can be a useful marker for inflammation in alopecia areata patients.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

Most children with MIS-C showed significant improvement by 6 months.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Prevention efforts should focus on body image, peer victimization, social programs, and sex education to reduce incel violence.

Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Dexmedetomidine-loaded microneedles effectively reduce pain without sedation.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

ZNF750 helps keep hair follicles healthy and prevents skin inflammation.

Inflammasome proteins can predict inflammation and outcomes in aneurysmal subarachnoid hemorrhage.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Korean Red Ginseng may improve skin condition and reduce allergy markers in atopic dermatitis patients.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Human placenta hydrolysate reduces inflammatory pain and nerve damage in mice.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Skin changes in obesity can indicate metabolic issues but aren't reliable for assessing risk or monitoring treatment.

Mesenchymal stem cells can effectively aid skin healing and anti-aging.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Charnoly bodies could be a marker for cell damage, and certain nutrients and proteins might prevent them, potentially helping with brain diseases and cancer.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.